This is not an official government website.
© 2026 PLEJ LC. All rights reserved.
Congressional Daily Record
This section tracks committee work such as meetings, reports, or referrals. It mentions legislation such as Combating Illicit Xylazine Act, committees such as Select Committee on Intelligence.
Official title: Daily Digest/COMMITTEE MEETINGS FOR 2026-07-20
Issued
July 18, 2026
People
0
No members linked from this section
Legislation
3
Bills and resolutions linked from this section
Committees
3
Committees connected to this section
Senate Holds
0
No hold activity linked here
Source Document
Connected Data
1 Helpful Term
Daily Digest
A plain-English recap published with the Congressional Record that summarizes what happened and what is scheduled next.
Source Control
Reader mode is for comprehension. The linked government PDF is the official published source.
Download official Daily Digest PDFReturn to issue contextCOMMITTEE MEETINGS FOR MONDAY,
JULY 20, 2026
(Committee meetings are open unless otherwise indicated)
Senate
House
Committee on Energy and Commerce, Full Committee, markup on H.R. 6529, the “Protecting Families from AI Data Center Energy Costs Act”; H.R. 6633, the “High-Capacity Grid Act”; H.R. 9332, the “Load Forecasting Enhancement Act”; H.R. 9335, the “Advanced Transmission Technology to Reduce Rates Act”; H.R. 9339, the “Affordable Innovation for the Grid Act”; H.R. 9340, the “Ratepayer Protection Act”; H.R. 9616, the “Environmental Monitoring and Remediation Technology Assessment Imitative (EMRTAI) Act of 2026”; H.R. 9617, the “Coordinating and Harnessing America's Recovery of Minerals (CHARM) Act”; H.R. 1266, the “Combating Illicit Xylazine Act”; H.R. 1561, the “ALERT Communities Act”; H.R. 2004, the “Tyler's Law”; H.R. 3514, the “Improving Seniors' Timely Access to Care Act of 2025”; H.R. 5243, to amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage; H.R. 5526, the “Biosimilar Red Tape Elimination Act”; H.R. 5880, the “Fight Illicit Pill Presses Act”; H.R. 7184, the “PRESS Act”; H.R. 7970, the “STOP Nitazenes Act”; H.R. 7994, the “HERO Act”; H.R. 8005, the “Stop Pills That Kill Act”; H.R. 8201, the “Expanding Community Access to Health Services Act”; H.R. 8908, the “STOP GAMES Act of 2026”; H.R. 9389, the “Nutrition Education and Chronic Disease Prevention in Community Health Centers Act of 2026”; H.R. 9390, the “Prices on
the Wall Act of 2026”; H.R. 9392, the “Medicare Advantage Cost Transparency Act”; H.R. 9393, the “Lower Costs, More Transparency Act of 2026”; H.R. 9396, the “Prior Authorization Accountability Act”; H.R. 9397, the “Premium Transparency Act”; H.R. 9661, the “Expedited Access to Biosimilars Act”; and H.R. 9338, the “Pipeline Safety Authorization Act of 2026”, 5 p.m., 2123 Rayburn.
Committee on Rules, Full Committee, hearing on H.R. 7008, the “Stop Insider Trading Act”; H.R. 6955, the “Main Street Capital Access Act”; legislation on establishing the congressional budget for the United States Government for fiscal year 2027 and setting forth the appropriate budgetary levels for fiscal years 2028 through 2036; legislation on Continuing Appropriations Act, 2027; H.R. 8800, the “National Defense Authorization Act for Fiscal Year 2027”; and H.R. 8884, the “Removing Barriers to Work for Disabled Americans Act”, 2 p.m., H-313 Capitol.
on H.R. 9624, the “Intelligence Authorization Act for Fiscal Year 2027”, 5:15 p.m., HVC-304.